SQI Diagnostics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SQIDF research report →
About the company
SQI Diagnostics Inc. operates as a precision medicine firm, engaged in the global identification, advancement, and marketing of swift diagnostic solutions tailored for medical professionals, patients, and the general public. Its diverse product portfolio features TOR-dx, a specialized lung test designed to help surgeons evaluate the condition of donor lungs.
- CEO
- Andrew Morris
- IPO
- 2009
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $6.07M
- P/E
- -0.45
- P/S
- 1.06
- P/B
- -0.84
- EV/EBITDA
- -2.34
- Div Yield
- 0.00%
- Gross Margin
- 38.30%
- Op Margin
- -241.42%
- Net Margin
- -228.62%
- ROE
- 447.09%
- ROIC
- -302.55%
- Revenue
- $8.10M · 783.53%
- Net Income
- $-18,523,000 · -75.46%
- EPS
- $-0.05 · -52.24%
- Op Income
- $-19,560,000
- FCF YoY
- -7.26%
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.36
- Avg Volume
- 0
Get TickerSpark's AI analysis on SQIDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SQIDF coverage
Recent articles, reports, and earnings notes.
No research on SQIDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SQIDF report →Similar companies
Peers in the same neighborhood.